2005
DOI: 10.1016/j.bbrc.2005.01.067
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of fatty acid synthase prevents preadipocyte differentiation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
83
0
1

Year Published

2007
2007
2015
2015

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 127 publications
(91 citation statements)
references
References 32 publications
7
83
0
1
Order By: Relevance
“…2). As expected, the well established required factors for adipocyte differentiation, PPAR␥ and FAS (21), did indeed attenuate PPAR␥ and GLUT4 expression in this screen when depleted by siRNA and acted as positive controls. In addition, rosiglitazone treatment did not restore PPAR␥ or GLUT4 levels upon siRNA-based depletion of PPAR␥ ( Fig.…”
Section: Expression Of Fatty Acid Metabolizing Enzymes In Culturedsupporting
confidence: 81%
See 1 more Smart Citation
“…2). As expected, the well established required factors for adipocyte differentiation, PPAR␥ and FAS (21), did indeed attenuate PPAR␥ and GLUT4 expression in this screen when depleted by siRNA and acted as positive controls. In addition, rosiglitazone treatment did not restore PPAR␥ or GLUT4 levels upon siRNA-based depletion of PPAR␥ ( Fig.…”
Section: Expression Of Fatty Acid Metabolizing Enzymes In Culturedsupporting
confidence: 81%
“…Furthermore, overexpression of sterol regulatory element-binding protein-1 (SREBP1) in adipocytes apparently increases ligand production (19), whereas inhibition of acetyl-CoA carboxylase (ACC) (20) or fatty acid synthase (FAS) (21) inhibits adipogenesis. SREBP1 is a transcription factor that controls the expression of many fatty acid metabolizing enzymes, including ACC and FAS.…”
mentioning
confidence: 99%
“…Previously, it has been shown that inhibition of FASN activity suppresses the expression of peroxisome proliferatoractivated receptor γ (PPARγ) in mice 3T3 cells (Schmid et al, 2005). Decreased PPARγ suppresses the expression of ACCα in human THP-1 cells (Chawla et al, 2001).…”
Section: Discussionmentioning
confidence: 99%
“…Triclosan is a potent inhibitor of the enoyl-acyl carrier protein reductase enzyme of the prokaryotic type II fatty acid synthase complex. Triclosan has also been reported to inhibit Type I fatty acid synthase in mammalian cells [29,30]. At concentrations shown not to be cytotoxic in preadipocytes (50 μM) [34] triclosan was a strong inhibitor of insulin release from islet cells (Figure 4) and INS-1 832/13 cells ( Figure 5).…”
Section: Inhibition Of Insulin Release By Inhibitors Of Lipogenesismentioning
confidence: 92%
“…Triclosan (5-chloro-2-(2,4-dichlorophenoxy)-phenol) was from Fluka BioChemika. Anti-actin (20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33) antibody (catalog number A5060) and other chemicals were from Sigma. INS-1 832/13 cells were from Chris Newgard [22].…”
Section: Experimental Procedures Materialsmentioning
confidence: 99%